Leading source of Financial News, Investor Forums, CEO Interviews, Financial Columnists, Stock Information

Pharma & Biotech

Add to MyProactive

Computer keyboard

Basic Materials

NA Proactive news snapshot: Allot Ltd, CytoDyn Inc, Group Eleven Resources Ltd UPDATE …

2 weeks, 1 day ago

Dragonglass jars made by Spirulinex LLC, a partly owned subsidiary of GSRX Industries

GSRX Industries is smoking hot as its dispensaries and CBD products generate strong revenue

2 weeks, 1 day ago

Microscope and research

CytoDyn marks major milestone for its leronlimab drug with first step into field of cancer

2 weeks, 1 day ago

CytoDyn - CytoDyn injects first breast cancer patient with its flagship therapy

Full interview: CytoDyn injects first breast cancer patient with its flagship therapy

2 weeks, 1 day ago

Zynerba Pharmaceuticals - Zynerba boosts cash position in 2Q, gears up for top-line data from key trials with Zygel CBD gel

Zynerba boosts cash position in 2Q, gears up for top-line data from key trials with Zygel CBD gel

2 weeks, 1 day ago

Health signs

Genprex says partner successfully completes manufacturing of TUSC2 plasmid DNA for Oncoprex gene therapy treatment

2 weeks, 1 day ago

Genprex, Inc. - Genprex Inc making progress on branding for its lead cancer therapy, Oncoprex

Genprex Inc making progress on branding for its lead cancer therapy, Oncoprex

2 weeks, 1 day ago

CytoDyn - UCytoDyn granted business waiver of application fees by FDA for Leronlimab BLA Filing

FDA waives application fees for CytoDyn's BLA filing for HIV drug Leronlimab

2 weeks, 2 days ago

Greenhouse

Asterion Cannabis' Queensland project gets big boost after government ruling

2 weeks, 5 days ago

Brain highlighted

Roth Capital reiterates Buy rating and $8 price target on Seelos Therapeutics following second quarter pipeline update

2 weeks, 5 days ago

1564765174_Screen-Shot-2019-08-02-at-12.15.02-PM.jpg

CytoDyn to apply to enter phase 2 clinical studies with PRO140 to treat colon cancer

2 weeks, 5 days ago

cannabis dollar sign

Buds & Duds: Cannabis shares in the green after major pot producer Aphria reports quarterly profit

2 weeks, 5 days ago

Birth control patch

Agile Therapeutics sets terms for $12 million public offering

2 weeks, 5 days ago

Coding error

Hemispherx Biopharma corrects reports that mistakenly inflated the value of its private placement

2 weeks, 5 days ago

Cannabis greenhouse

The Green Organic Dutchman extends licenses at Ancaster cannabis facility until August 2022

2 weeks, 5 days ago

Lab technician

Lexaria Bioscience hires Integra Consulting for investor relations services

2 weeks, 5 days ago

Doctor gesturing toward a colon graphic

CytoDyn successfully completes preclinical colon cancer treatment studies

2 weeks, 5 days ago

CBD oil

Exactus expands with acquisition of Green Goddess Extracts, a highly regarded Florida contract manufacturer and formulator of hemp and vape products

2 weeks, 5 days ago

Botanix Pharmaceuticals raises $40mln to push its CBD-based skin disease treatments through the pipeline

Botanix Pharmaceuticals raises $40mln to push its CBD-based skin disease treatments through the pipeline

2 weeks, 6 days ago

Hemp farm

Healthcare company Exactus has diversified to pursue opportunities in hemp derived CBD products

2 weeks, 6 days ago

Recommended

The rise, fall, and probable rise again of cobalt

6 days, 14 hours ago

Pure Gold Mining secures funds to begin construction process of Madsen Red Lake mine

6 days, 12 hours ago

Follow us on:

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority. Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use